These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2876775)

  • 1. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
    Germouty J
    Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tulobuterol in the management of obstructive airways disease in adults.
    Patel KR
    Clin Ther; 1985; 7(4):452-67. PubMed ID: 2861899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.
    Schaffler K; Reeh PW
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):673-82. PubMed ID: 2893778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of asthma with tulobuterol or albuterol in school-age children.
    Le Bourgeois M; de Blic J; Chauvin JP; Scheinmann P; Paupe J
    Clin Ther; 1990; 12(6):513-9. PubMed ID: 2289220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction.
    Maesen F; Smeets J; Polderman J
    Arzneimittelforschung; 1983; 33(12):1696-8. PubMed ID: 6365104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
    Ulrik CS
    Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: a dose-response study.
    Bennis J; Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():113-7. PubMed ID: 343234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
    Lin Q; Liu QH; Bao YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a B2 adrenergic agonist and an anticholinergic agent given by sequential inhalation in patients with severe chronic obstructive pulmonary disease.
    Heimer D; Brami JL; Liberman D; Bark H
    Isr J Med Sci; 1991 Jun; 27(6):307-10. PubMed ID: 1676394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients.
    Sanchez J; Rivero A; Dal-Re R; Azanza JR
    Int J Clin Pharmacol Res; 1988; 8(4):279-85. PubMed ID: 3182119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
    Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
    Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.